Venlafaxine in the treatment of panic disorder

Venlafaxine XR is a novel, dual acting SNRI antidepressant, which inhibits both serotonin and norepinephrine reuptake. Controlled trials have demonstrated the efficacy and safety of venlafaxine in the treatment of panic disorder. Generally well tolerated, with side-effects that usually abate with co...

Descripción completa

Detalles Bibliográficos
Autores principales: Katzman, Martin A, Jacobs, Leslie
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654536/
https://www.ncbi.nlm.nih.gov/pubmed/19300538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654536/
https://www.ncbi.nlm.nih.gov/pubmed/19300538

Ejemplares similares